FDA clears Medtronic’s Hugo robot for 3.5 million abdominal surgeries
Medtronic has gained FDA clearance to use its Hugo surgical robot in upper and lower abdominal procedures, addressing a market of 3.5 million annual operations.
Pick the topics you care about. Your homepage shows them first. No account needed.
Get new stories on your phone
Keep your saved stories, streak and topics on every device. Free. No password.
New here? The same steps create your free account. By signing in you agree to our Terms and Privacy policy.
Check your email. We sent a sign-in link to . It works for 20 minutes.
or wait a minute and send it again.
Medtronic has gained FDA clearance to use its Hugo surgical robot in upper and lower abdominal procedures, addressing a market of 3.5 million annual operations.